MDXH.US MDxHealth SA

Healthcare Biotechnology USA Stocks
0.1441 USD
Close of Nov 15, 2026
0.1128 4.34
Market cap
USD 13.7M
P/E
-
P/B
23.64x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MDXH.US undervalued?

Graham number

The Graham number of MDxHealth SA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MDxHealth SA fundamental analysis

No fundamental analysis for MDxHealth SA yet.

MDxHealth SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary trac…

Full company profile